FDA Gives Approval for Marijuana Oil Study

MONTGOMERY, Ala. (AP) – The Food and Drug Administration is giving the University of Alabama at Birmingham the green light to study the use of a marijuana derivative to treat seizures.

Parents of children with seizure disorders persuaded the Alabama Legislature last year to pass a bill authorizing UAB’s Department of Neurology to do a study of the marijuana derivative cannabidiol as a seizure treatment.

A UAB spokesman said Wednesday that the FDA has approved the study, but has requested modifications. A university review board will discuss the changes next month. The study will provide all participants with access to the oil, instead of giving placebos.

Lawmakers approved the study after a decriminalization bill stalled. The bill is known as “Carly’s Law” for Carly Chandler of Pelham, who suffers frequent seizures.

(Copyright 2014 The Associated Press. All rights reserved. This material may not be published, broadcast, rewritten or redistributed.)

Categories: Montgomery Metro, News